Seroatlas · Human Serome Atlas

OR4E2

Olfactory receptor 4E2

Also known as: OR4E2_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8NGC2
Gene
OR4E2
Canonical length
313 aa
Protein class
Predicted membrane proteins

OverviewNCBI Gene

No narrative summary is available for OR4E2 in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

313 residues, UniProt reviewed canonical sequence.

>Q8NGC2|OR4E2
     1  MDSLNQTRVT EFVFLGLTDN RVLEMLFFMA FSAIYMLTLS GNILIIIATV FTPSLHTPMY
    61  FFLSNLSFID ICHSSVTVPK MLEGLLLERK TISFDNCITQ LFFLHLFACA EIFLLIIVAY
   121  DRYVAICTPL HYPNVMNMRV CIQLVFALWL GGTVHSLGQT FLTIRLPYCG PNIIDSYFCD
   181  VPLVIKLACT DTYLTGILIV TNSGTISLSC FLAVVTSYMV ILVSLRKHSA EGRQKALSTC
   241  SAHFMVVALF FGPCIFIYTR PDTSFSIDKV VSVFYTVVTP LLNPFIYTLR NEEVKSAMKQ
   301  LRQRQVFFTK SYT

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against OR4E2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
7
Mean surface accessibility (rSASA)
0.26
Highest tissue expression
0 nTPM

Expression across tissuesHPA

Tissue

  • adipose tissue: 0 nTPM
  • adrenal gland: 0 nTPM
  • amygdala: 0 nTPM
  • appendix: 0 nTPM
  • basal ganglia: 0 nTPM
  • blood vessel: 0 nTPM

Single-cell type

  • early spermatids: 3.3 nCPM
  • cholangiocytes: 2 nCPM
  • late primary spermatocytes: 0.3 nCPM
  • podocytes: 0.3 nCPM
  • b-cells: 0.2 nCPM
  • breast secretory cells: 0.2 nCPM

Immune cell

  • basophil: 0.1 nTPM
  • classical monocyte: 0 nTPM
  • eosinophil: 0 nTPM
  • gdT-cell: 0 nTPM
  • intermediate monocyte: 0 nTPM
  • MAIT T-cell: 0 nTPM

Brain region

  • cerebellum: 0.8 nTPM
  • cerebral cortex: 0.7 nTPM
  • basal ganglia: 0.6 nTPM
  • hippocampal formation: 0.6 nTPM
  • amygdala: 0.5 nTPM
  • pons: 0.5 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.48
gnomAD pLI
0.01
gnomAD missense Z
-0.73
DepMap mean gene effect
-0.09
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads OR4E2 as an antibody target. Whether an autoantibody or antibody against OR4E2 could matter depends on whether native OR4E2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

OR4E2 is annotated at the cell surface, where native OR4E2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label OR4E2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/OR4E2. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...